Live news related to IPSEN stock (FR0010259150): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The French biopharmaceutical group has entered into an exclusive licensing agreement with Simcere Zaiming for SIM0613, an experimental antibody-drug c…
French laboratory Ipsen has announced the discontinuation of its Phase II FALKON trial on fidrisertib, following the failure to meet the primary endpo…
The French pharmaceutical group announced this Sunday that it has completed the acquisition of ImCheck Therapeutics, a private French company speciali…
Ipsen has announced the transfer of shares from Beech Tree company to the Alasol Foundation, in accordance with the wishes of Mr. Henri Beaufour.
Ipsen announces the passing of Henri Beaufour, influential board member, which occurred on November 28, 2025.
